These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 26449252

  • 1. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
    Zhang Y, Pan KF, Zhang L, Ma JL, Zhou T, Li JY, Shen L, You WC.
    Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
    [Abstract] [Full Text] [Related]

  • 2. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
    Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, Liu WD, Feng GS, Zhang XD, Li J, Lu AP, Xia HH, Lam S, You WC.
    Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
    [Abstract] [Full Text] [Related]

  • 3. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
    You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF, Xu GW, Gail MH.
    J Natl Cancer Inst; 2006 Jul 19; 98(14):974-83. PubMed ID: 16849680
    [Abstract] [Full Text] [Related]

  • 4. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D, He Q, Liu C.
    J Gastroenterol Hepatol; 2010 Apr 19; 25(4):795-9. PubMed ID: 20492336
    [Abstract] [Full Text] [Related]

  • 5. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.
    Zhang LJ, Wang SY, Huo XH, Zhu ZL, Chu JK, Ma JC, Cui DS, Gu P, Zhao ZR, Wang MW, Yu J.
    World J Gastroenterol; 2009 Jun 14; 15(22):2731-8. PubMed ID: 19522023
    [Abstract] [Full Text] [Related]

  • 6. Alterations of Cyclooxygenase-2 Methylation Levels Before and After Intervention Trial to Prevent Gastric Cancer in a Chinese Population.
    Zhang Y, Zeng HM, Nie XR, Zhang L, Ma JL, Li JY, Pan KF, You WC.
    Cancer Prev Res (Phila); 2016 Jun 14; 9(6):484-90. PubMed ID: 27020655
    [Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS, China Gastric Cancer Study Group.
    JAMA; 2004 Jan 14; 291(2):187-94. PubMed ID: 14722144
    [Abstract] [Full Text] [Related]

  • 8. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ.
    Gut; 2004 Sep 14; 53(9):1244-9. PubMed ID: 15306578
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions.
    Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, Chan FK.
    Am J Pathol; 2000 Sep 14; 157(3):729-35. PubMed ID: 10980112
    [Abstract] [Full Text] [Related]

  • 11. Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis.
    Shao Y, Sun K, Xu W, Li XL, Shen H, Sun WH.
    World J Gastroenterol; 2014 Sep 28; 20(36):12860-73. PubMed ID: 25278683
    [Abstract] [Full Text] [Related]

  • 12. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
    Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R.
    J Natl Cancer Inst; 2000 Dec 06; 92(23):1881-8. PubMed ID: 11106679
    [Abstract] [Full Text] [Related]

  • 13. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study.
    Dong CX, Deng DJ, Pan KF, Zhang L, Zhang Y, Zhou J, You WC.
    Int J Cancer; 2009 Jan 15; 124(2):434-9. PubMed ID: 18821580
    [Abstract] [Full Text] [Related]

  • 14. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
    Pan KF, Zhang L, Gerhard M, Ma JL, Liu WD, Ulm K, Wang JX, Zhang L, Zhang Y, Bajbouj M, Zhang LF, Li M, Vieth M, Liu RY, Quante M, Wang LH, Suchanek S, Zhou T, Guan WX, Schmid R, Classen M, You WC.
    Gut; 2016 Jan 15; 65(1):9-18. PubMed ID: 25986943
    [Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, Li JY, Zhao L, Liu WD, Zhang JS, Ma JL, Samloff IM, Correa P, Blaser MJ, Xu GW, Fraumeni JF.
    Cancer Epidemiol Biomarkers Prev; 1996 Aug 15; 5(8):627-30. PubMed ID: 8824365
    [Abstract] [Full Text] [Related]

  • 16. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
    Tang BD, Zeng ZR, Hu PJ.
    Ai Zheng; 2006 Oct 15; 25(10):1205-9. PubMed ID: 17059761
    [Abstract] [Full Text] [Related]

  • 17. Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
    He C, Kong F, Zhu X, Kong F, Zhao W, Liu Y, Wang K.
    Biomed Res Int; 2021 Oct 15; 2021():4171019. PubMed ID: 34888378
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
    Miehlke S, Kirsch C, Dragosics B, Gschwantler M, Oberhuber G, Antos D, Dite P, Läuter J, Labenz J, Leodolter A, Malfertheiner P, Neubauer A, Ehninger G, Stolte M, Bayerdörffer E.
    World J Gastroenterol; 2001 Apr 15; 7(2):243-7. PubMed ID: 11819768
    [Abstract] [Full Text] [Related]

  • 19. Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
    Muñoz N, Vivas J, Buiatti E, Kato I, Oliver W.
    IARC Sci Publ; 1996 Apr 15; (139):125-33. PubMed ID: 8923024
    [Abstract] [Full Text] [Related]

  • 20. The long-term effect of Helicobacter pylori eradication on COX-1/2, 5-LOX and leukotriene receptors in patients with a risk gastritis phenotype--a link to gastric carcinogenesis.
    Venerito M, Kuester D, Wex T, Roessner A, Malfertheiner P, Treiber G.
    Cancer Lett; 2008 Nov 08; 270(2):218-28. PubMed ID: 18571838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.